Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study-Reference-Cited by-同舟云学术

Tolerability of isradipine in early Parkinson's disease: A pilot dose escalation study

Published:2010-09-03 Issue:16 Volume:25 Page:2863-2866
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Simuni Tanya,Borushko Emily,Avram Michael J.,Miskevics Scott,Martel Audrey,Zadikoff C.,Videnovic Aleksandar,Weaver Frances M.,Williams Karen,Surmeier D. James

Funder

Northwestern Foundation Dixon Translational

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.23308/fullpdf

Reference11 articles.

1. ‘Rejuvenation’ protects neurons in mouse models of Parkinson's disease;Chan;Nature,2007

2. Use of antihypertensives and the risk of Parkinson disease;Becker;Neurology,2008

3. L-type calcium channel blockers and Parkinson disease in Denmark;Ritz;Ann Neurol,2010

4. Teaching tape for the motor section of the unified Parkinson's disease rating scale;Goetz;Mov Disord,1995

5. Parkinsonism: onset, progression and mortality;Hoehn;Neurology,1967

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment;Pharmacological Reviews;2023-03-14

2. Insights into Neurodegeneration in Parkinson's Disease from Single‐Cell and Spatial Genomics;Movement Disorders;2023-03-07

3. The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders;Current Neuropharmacology;2023-02

4. Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection;Pharmacological Reviews;2021-10

5. Medical treatment of the motor features of Parkinson disease;Principles and Practice of Movement Disorders;2021